ER stress induced immunopathology involving complement in CADASIL: implications for therapeutics.

CADASIL Complement Interleukin 6 Intracellular adhesion molecule Stroke Vascular smooth muscle cells

Journal

Acta neuropathologica communications
ISSN: 2051-5960
Titre abrégé: Acta Neuropathol Commun
Pays: England
ID NLM: 101610673

Informations de publication

Date de publication:
08 05 2023
Historique:
received: 30 12 2022
accepted: 26 03 2023
medline: 11 5 2023
pubmed: 9 5 2023
entrez: 9 5 2023
Statut: epublish

Résumé

Cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is caused by NOTCH3 mutations. Typical CADASIL is characterised by subcortical ischemic strokes due to severe arteriopathy and fibrotic thickening of small arteries. Arteriolar vascular smooth muscle cells (VSMCs) are the key target in CADASIL, but the potential mechanisms involved in their degeneration are still unclear. Focusing on cerebral microvessels in the frontal and anterior temporal lobes and the basal ganglia, we used advanced proteomic and immunohistochemical methods to explore the extent of inflammatory and immune responses in CADASIL subjects compared to similar age normal and other disease controls. There was variable loss of VSMC in medial layers of arteries in white matter as well as the cortex, that could not be distinguished whether NOTCH3 mutations were in the epidermal growth factor (EGFr) domains 1-6 or EGFr7-34. Proteomics of isolated cerebral microvessels showed alterations in several proteins, many associated with endoplasmic reticulum (ER) stress including heat shock proteins. Cerebral vessels with sparsely populated VSMCs also attracted robust accrual of perivascular microglia/macrophages in order CD45

Identifiants

pubmed: 37158955
doi: 10.1186/s40478-023-01558-1
pii: 10.1186/s40478-023-01558-1
pmc: PMC10169505
doi:

Substances chimiques

Intercellular Adhesion Molecule-1 126547-89-5
Complement System Proteins 9007-36-7

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

76

Subventions

Organisme : NIA NIH HHS
ID : RF1NS110048
Pays : United States
Organisme : Medical Research Council
ID : G0500247
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0400074
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom

Informations de copyright

© 2023. The Author(s).

Références

BMC Biol. 2020 Nov 24;18(1):175
pubmed: 33234129
Cereb Circ Cogn Behav. 2021;2:100031
pubmed: 34950895
Trends Mol Med. 2012 Oct;18(10):589-98
pubmed: 22883813
Nature. 1996 Oct 24;383(6602):707-10
pubmed: 8878478
Neurogenetics. 2011 Nov;12(4):337-43
pubmed: 21881852
Am J Pathol. 2003 Jan;162(1):329-42
pubmed: 12507916
Alzheimers Dement. 2018 Mar;14(3):280-292
pubmed: 29055812
Acta Neuropathol. 1996 Oct;92(4):341-50
pubmed: 8891065
Eur J Cell Biol. 2018 Nov;97(8):557-567
pubmed: 30392756
Nat Immunol. 2010 Sep;11(9):785-97
pubmed: 20720586
J Neuropathol Exp Neurol. 2013 May;72(5):416-31
pubmed: 23584202
Stroke. 2022 Dec;53(12):3696-3705
pubmed: 36205142
Stroke. 2002 Nov;33(11):2565-9
pubmed: 12411643
Stroke. 2006 Sep;37(9):2242-7
pubmed: 16873707
Immunobiology. 1998 Jul;199(1):5-13
pubmed: 9717663
Neurology. 2012 Jan 17;78(3):167-74
pubmed: 22170884
J Neurol Sci. 2017 Aug 15;379:69-76
pubmed: 28716282
J Neuroimmunol. 1997 Mar;73(1-2):63-9
pubmed: 9058760
Neurology. 1999 Jul 13;53(1):233
pubmed: 10408571
J Neurol Neurosurg Psychiatry. 2011 Aug;82(8):855-60
pubmed: 21217157
Folia Neuropathol. 2016;54(4):375-381
pubmed: 28139819
Neurol Res. 2004 Jul;26(5):558-62
pubmed: 15265274
J Cereb Blood Flow Metab. 2012 Dec;32(12):2171-80
pubmed: 22948298
Cerebrovasc Dis. 2014;38(4):302-7
pubmed: 25412914
Neuropathol Appl Neurobiol. 2015 Jun;41(4):557-70
pubmed: 25303037
Methods Mol Biol. 2012;849:261-74
pubmed: 22528096
Hum Mol Genet. 2009 Aug 1;18(15):2761-7
pubmed: 19417009
Stroke. 2009 Jun;40(6):2004-11
pubmed: 19359623
Atherosclerosis. 2022 Jun;351:29-40
pubmed: 35365353
Br J Dermatol. 2005 Feb;152(2):346-9
pubmed: 15727650
Mol Med. 2007 May-Jun;13(5-6):305-14
pubmed: 17622327
Stroke. 1993 Jan;24(1):122-5
pubmed: 8418535
Neuroreport. 2006 Jul 17;17(10):945-9
pubmed: 16791082
Stroke. 2010 Feb;41(2):218-23
pubmed: 20035077
EMBO Mol Med. 2023 Feb 8;15(2):e16556
pubmed: 36524456
Neurosci Lett. 2000 Mar 24;282(3):149-52
pubmed: 10717413
Neuropathol Appl Neurobiol. 2014 Aug;40(5):591-602
pubmed: 23844775
Acta Neuropathol. 2018 Jul;136(1):111-125
pubmed: 29725820
J Cell Biol. 1974 Mar;60(3):673-84
pubmed: 4363161
Neurochem Int. 2010 Nov;57(6):668-75
pubmed: 20705111
J Clin Invest. 2000 Mar;105(5):597-605
pubmed: 10712431
J Immunol. 2012 Nov 1;189(9):4640-7
pubmed: 23028050
Clin Transl Sci. 2011 Jun;4(3):146-52
pubmed: 21707943
J Therm Biol. 2017 Oct;69:149-154
pubmed: 29037376
Acta Neuropathol. 2016 May;131(5):659-85
pubmed: 27062261
Hum Mol Genet. 2010 Jan 1;19(1):79-89
pubmed: 19825845
J Biol Chem. 2002 Jun 14;277(24):21723-9
pubmed: 11925448
Clin Neurol Neurosurg. 2018 Oct;173:196-199
pubmed: 29449082
J Mol Cell Cardiol. 2013 Jan;54:65-72
pubmed: 23154128
JCI Insight. 2019 Dec 5;4(23):
pubmed: 31647781
Stroke. 2020 Dec;51(12):3482-3484
pubmed: 33161845
Brain. 2011 Dec;134(Pt 12):3716-27
pubmed: 22171356
J Immunol. 2019 Oct 1;203(7):1973-1980
pubmed: 31492744
Neurobiol Aging. 2000 May 1;21(3):451-453
pubmed: 10858594
Proc Natl Acad Sci U S A. 2011 May 24;108(21):E128-35
pubmed: 21555590
Antioxid Redox Signal. 2013 Jun 10;18(17):2352-63
pubmed: 22900885
Brain Pathol. 2014 Sep;24(5):525-44
pubmed: 25323668
Acta Neuropathol. 2012 Jan;123(1):1-11
pubmed: 22101365
Front Genet. 2020 Sep 15;11:1022
pubmed: 33101365
J Cell Mol Med. 2018 Jun;22(6):3016-3024
pubmed: 29536621
Neuropathology. 2018 Dec;38(6):601-608
pubmed: 30402942
Am J Pathol. 1986 Mar;122(3):410-20
pubmed: 2420184
Exp Cell Res. 2013 Feb 1;319(3):134-43
pubmed: 23036509
J Cell Physiol. 2009 May;219(2):494-502
pubmed: 19180562
Rinsho Shinkeigaku. 1997 Oct;37(10):910-6
pubmed: 9490903
Brain. 2013 Jun;136(Pt 6):1830-45
pubmed: 23649698

Auteurs

Mahmod Panahi (M)

Department of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Clinical Geriatrics, Karolinska Institutet, BioClinicum J9:20 Visionsgatan 4, Solna, 171 64, Sweden.

Yoshiki Hase (Y)

Translational and Clinical Research Institute, Campus for Ageing and Vitality, Newcastle University, Newcastle upon Tyne, NE4 5PL, UK.

Xavier Gallart-Palau (X)

Biomedical Research Institute of Lleida (IRBLLEIDA) - +Pec Proteomics Research Group (+PPRG) - Neuroscience Area, University Hospital Arnau de Vilanova (HUAV) - Department of Psychology, University of Lleida (UdL), Lleida, Spain.

Sumonto Mitra (S)

Department of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Clinical Geriatrics, Karolinska Institutet, BioClinicum J9:20 Visionsgatan 4, Solna, 171 64, Sweden.

Atsushi Watanabe (A)

Equipment Management Division, Center for Core Facility Administration, Research Institute, National Center for Geriatrics and Gerontology (NCGG), 7-430, Morioka-cho, Obu-shi, 474-8511, Aichi, Japan.

Roger C Low (RC)

Translational and Clinical Research Institute, Campus for Ageing and Vitality, Newcastle University, Newcastle upon Tyne, NE4 5PL, UK.

Yumi Yamamoto (Y)

Department of Molecular Innovation in Lipidemiology and Department of Neurology, National Cerebral and Cardiovascular Center, 6-1 Kishibeshinmachi, Suita, 564-8565, Osaka, Japan.

Diego Sepulveda-Falla (D)

Molecular Neuropathology of Alzheimer's Disease, Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, 20246, Hamburg, Germany.

Atticus H Hainsworth (AH)

Molecular and Clinical Sciences, St George's University of London, Cranmer Terrace, London, SW17 0RE, UK.

Masafumi Ihara (M)

Department of Molecular Innovation in Lipidemiology and Department of Neurology, National Cerebral and Cardiovascular Center, 6-1 Kishibeshinmachi, Suita, 564-8565, Osaka, Japan.

Siu Kwan Sze (SK)

Faculty of Applied Health Sciences, Brock University, St. Catharines, ON, L2S 3A1, Canada.

Matti Viitanen (M)

Department of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Clinical Geriatrics, Karolinska Institutet, BioClinicum J9:20 Visionsgatan 4, Solna, 171 64, Sweden.
Department of Geriatrics, University of Turku, Turku City Hospital, Kunnallissairaalantie 20, Turku, 20700, Finland.

Homira Behbahani (H)

Department of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Clinical Geriatrics, Karolinska Institutet, BioClinicum J9:20 Visionsgatan 4, Solna, 171 64, Sweden.

Raj N Kalaria (RN)

Translational and Clinical Research Institute, Campus for Ageing and Vitality, Newcastle University, Newcastle upon Tyne, NE4 5PL, UK. raj.kalaria@newcastle.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH